L3VLUP
← Every manager
Free · no sign-up · Q2 2026

Which funds own XENE

Xenon Pharmaceuticals Inc in the Q2 2026 filings. At least 1 of the 91 current managers on file reported a position, worth $253m between them. It is among the largest positions of fewer than a fifth of the current managers on file. Buying and selling roughly cancelled this quarter, which is what a name looks like when the argument is still live.

Managers holding
1
at least, of 91 current
Combined value
$253m
as reported
Opened
0
new this quarter
Added to
1
already held
Trimmed or sold out
1
1 sold out entirely

Only each manager’s largest 200 positions are listed here, so a smaller holder may be missing.

Managers reporting a position

Largest first. Weight is the share of that manager’s whole reported book, which is the number worth quoting: $400m is a rounding error in one book and a defining bet in another.

ManagerValueWeightSharesChange on the quarterAction
Janus Henderson Group Ltd
Long-only · $245bn book
$253m0.1%4,186,519+$9.8m+10,537Added

Sold out of this quarter

Valued at what the position was worth in the previous filing, because by this one it is gone.

Ownership through time

At least 9 of the 95 managers whose filings are on file listed XENE in Q2 2026, against 1 in Q4 2014. 1 manager more than in Q1 2026: 1 started a position; 2 listed it again; 2 no longer listed it among the positions read, which can mean a holding below the listed range, a filing that reported no holdings, or a filing not yet made.

Each manager’s largest 500 positions a quarter are read, so a small holding in a very large book can be missing, and a manager is counted as leaving only where its own filing shows it.

Managers on file listing it
0611Q4 2014: 1Q1 2015: 115Q3 2015: 1Q4 2015: 1Q1 2016: 116Q2 2016: 1Q3 2016: 1Q4 2016: 1Q1 2017: 117Q2 2017: 2Q3 2017: 2Q4 2017: 2Q1 2018: 218Q2 2018: 3Q3 2018: 5Q4 2018: 3Q1 2019: 419Q2 2019: 3Q3 2019: 3Q4 2019: 3Q1 2020: 220Q2 2020: 3Q1 2021: 121Q2 2021: 1Q3 2021: 2Q4 2021: 4Q1 2022: 622Q2 2022: 7Q3 2022: 7Q4 2022: 8Q1 2023: 923Q2 2023: 5Q3 2023: 7Q4 2023: 11Q1 2024: 624Q2 2024: 7Q3 2024: 7Q4 2024: 6Q1 2025: 525Q2 2025: 5Q3 2025: 5Q4 2025: 6Q1 2026: 826Q2 2026: 9
  • Q4 2014: 1
  • Q1 2015: 1
  • Q3 2015: 1
  • Q4 2015: 1
  • Q1 2016: 1
  • Q2 2016: 1
  • Q3 2016: 1
  • Q4 2016: 1
  • Q1 2017: 1
  • Q2 2017: 2
  • Q3 2017: 2
  • Q4 2017: 2
  • Q1 2018: 2
  • Q2 2018: 3
  • Q3 2018: 5
  • Q4 2018: 3
  • Q1 2019: 4
  • Q2 2019: 3
  • Q3 2019: 3
  • Q4 2019: 3
  • Q1 2020: 2
  • Q2 2020: 3
  • Q1 2021: 1
  • Q2 2021: 1
  • Q3 2021: 2
  • Q4 2021: 4
  • Q1 2022: 6
  • Q2 2022: 7
  • Q3 2022: 7
  • Q4 2022: 8
  • Q1 2023: 9
  • Q2 2023: 5
  • Q3 2023: 7
  • Q4 2023: 11
  • Q1 2024: 6
  • Q2 2024: 7
  • Q3 2024: 7
  • Q4 2024: 6
  • Q1 2025: 5
  • Q2 2025: 5
  • Q3 2025: 5
  • Q4 2025: 6
  • Q1 2026: 8
  • Q2 2026: 9
Their combined reported value
$0$674m$1bnQ4 2014: $12mQ1 2015: $11m15Q3 2015: $8.5mQ4 2015: $8.3mQ1 2016: $7.2m16Q2 2016: $6.1mQ3 2016: $8.3mQ4 2016: $9.4mQ1 2017: $5.7m17Q2 2017: $4.9mQ3 2017: $5.0mQ4 2017: $5.1mQ1 2018: $8.9m18Q2 2018: $17mQ3 2018: $21mQ4 2018: $9.5mQ1 2019: $24m19Q2 2019: $19mQ3 2019: $17mQ4 2019: $25mQ1 2020: $18m20Q2 2020: $21mQ1 2021: $14m21Q2 2021: $17mQ3 2021: $20mQ4 2021: $205mQ1 2022: $215m22Q2 2022: $230mQ3 2022: $330mQ4 2022: $303mQ1 2023: $259m23Q2 2023: $222mQ3 2023: $220mQ4 2023: $590mQ1 2024: $396m24Q2 2024: $383mQ3 2024: $428mQ4 2024: $400mQ1 2025: $343m25Q2 2025: $224mQ3 2025: $415mQ4 2025: $501mQ1 2026: $1.3bn26Q2 2026: $1.2bn
  • Q4 2014: $12m
  • Q1 2015: $11m
  • Q3 2015: $8.5m
  • Q4 2015: $8.3m
  • Q1 2016: $7.2m
  • Q2 2016: $6.1m
  • Q3 2016: $8.3m
  • Q4 2016: $9.4m
  • Q1 2017: $5.7m
  • Q2 2017: $4.9m
  • Q3 2017: $5.0m
  • Q4 2017: $5.1m
  • Q1 2018: $8.9m
  • Q2 2018: $17m
  • Q3 2018: $21m
  • Q4 2018: $9.5m
  • Q1 2019: $24m
  • Q2 2019: $19m
  • Q3 2019: $17m
  • Q4 2019: $25m
  • Q1 2020: $18m
  • Q2 2020: $21m
  • Q1 2021: $14m
  • Q2 2021: $17m
  • Q3 2021: $20m
  • Q4 2021: $205m
  • Q1 2022: $215m
  • Q2 2022: $230m
  • Q3 2022: $330m
  • Q4 2022: $303m
  • Q1 2023: $259m
  • Q2 2023: $222m
  • Q3 2023: $220m
  • Q4 2023: $590m
  • Q1 2024: $396m
  • Q2 2024: $383m
  • Q3 2024: $428m
  • Q4 2024: $400m
  • Q1 2025: $343m
  • Q2 2025: $224m
  • Q3 2025: $415m
  • Q4 2025: $501m
  • Q1 2026: $1.3bn
  • Q2 2026: $1.2bn

Between the quarter ends of Q1 2026 and Q2 2026. Each change in shares is valued at the Q2 2026 price, so the price’s own move is left out; a 13F shows the two quarter ends, not when in between anything was bought or sold.

Started in Q2 2026

Largest increases, by shares

Largest decreases, by shares

Left it

No manager on file is shown leaving it.

ManagerValue over timeFirst listedLargestQ2 2026
Fidelity (FMR LLC)Q1 2026$629m$582m
Janus Henderson Group LtdQ4 2023$253m$253m
Two Sigma Investments LPQ4 2023$99m$99m
AllianceBernstein LPQ4 2023$91m$91m
Capital World InvestorsQ4 2014$124m$52m
Marshall Wace LLPQ4 2021$101m$42m
Tudor Investment CorpQ1 2026$33m$33m
Schonfeld Strategic Advisors LLCQ2 2017$19m$14m
ExodusPoint Capital Management LPQ1 2023$14m$5.1m
Wellington Management Group LLPQ4 2023$281mlast listed Q1 2026
Point72 Asset Management LPQ1 2019$93mlast listed Q2 2024
Holocene Advisors LPQ1 2022$88mlast listed Q1 2026
Woodline Partners LPQ3 2021$15mlast listed Q4 2023
Two Sigma Advisers LPQ4 2023$12mlast listed Q4 2025
Moore Capital Management LPQ3 2018$6.3mlast listed Q4 2025
Walleye Capital LLCQ3 2018$4.9mlast listed Q1 2023
PDT Partners LLCQ2 2018$372klast listed Q2 2020

What XENE is worth

Knowing who owns it is half the question. The other half is what it is worth against the companies it trades beside, which is the one an interviewer will follow up with.

Build the comp set around XENE →

How much of the picture this is

A Form 13F reports US-listed long equity and nothing else: no shorts, no bonds, no cash and no non-US listings. It arrives forty-five days after the quarter ends, so a manager who sold in July still shows the position in a filing published in August. This page reads the managers on file here rather than every filer in the market, and each manager’s largest positions rather than the whole table, so a small position in a very large book may not appear. Say “their last filing showed” rather than “they own”, and the distinction will do you credit.

What to do with a name the funds are buying

Knowing who owns something is the start of a pitch, not the pitch. The next questions are what it is worth and why they were buying.

Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More

The holdings, every quarter, and the week between

One email a week on what moved in the market and what it means for the people interviewing into it, with the 13F changes the quarter they are filed.

One email a week, free, and you can leave at any point.